OneChain’s CAR-T therapy OC-1 shows encouraging interim results in aggressive blood cancer

by OneChain Immunotherapeutics

New preliminary data presented at EHA 2026 highlight the potential of OC-1 in a rare and aggressive blood cancer with limited treatment options.

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

A new strategy against pancreatic cancer...

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

The study analyses the role of PARP2 protein in tumour development and...

Photos Stream